SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-315813
Filing Date
2018-11-01
Accepted
2018-11-01 16:29:59
Documents
4
Period of Report
2018-11-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d647636d8k.htm 8-K 19648
2 EX-1.1 d647636dex11.htm EX-1.1 152749
3 EX-5.1 d647636dex51.htm EX-5.1 8610
4 GRAPHIC g647636g71a37.gif GRAPHIC 5901
  Complete submission text file 0001193125-18-315813.txt   190495
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-28386 | Film No.: 181154176
SIC: 2834 Pharmaceutical Preparations